510 related articles for article (PubMed ID: 18957199)
21. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.
Bruggeman SW; Valk-Lingbeek ME; van der Stoop PP; Jacobs JJ; Kieboom K; Tanger E; Hulsman D; Leung C; Arsenijevic Y; Marino S; van Lohuizen M
Genes Dev; 2005 Jun; 19(12):1438-43. PubMed ID: 15964995
[TBL] [Abstract][Full Text] [Related]
22. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.
Baker DJ; Perez-Terzic C; Jin F; Pitel KS; Niederländer NJ; Jeganathan K; Yamada S; Reyes S; Rowe L; Hiddinga HJ; Eberhardt NL; Terzic A; van Deursen JM
Nat Cell Biol; 2008 Jul; 10(7):825-36. PubMed ID: 18516091
[TBL] [Abstract][Full Text] [Related]
23. The transcription factor Slug represses p16
Zhu P; Zhang C; Gao Y; Wu F; Zhou Y; Wu WS
Nat Commun; 2019 Jun; 10(1):2568. PubMed ID: 31189923
[TBL] [Abstract][Full Text] [Related]
24. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
[TBL] [Abstract][Full Text] [Related]
25. Specific Deletion of p16
Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A
Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051
[TBL] [Abstract][Full Text] [Related]
26. The Role of p16
D'Arcangelo D; Tinaburri L; Dellambra E
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28737694
[TBL] [Abstract][Full Text] [Related]
27. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
[TBL] [Abstract][Full Text] [Related]
28. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors.
Pardal R; Molofsky AV; He S; Morrison SJ
Cold Spring Harb Symp Quant Biol; 2005; 70():177-85. PubMed ID: 16869752
[TBL] [Abstract][Full Text] [Related]
29. Toxicology and carcinogenesis study of glycidol (CAS No. 556-52-5) in genetically modified haploinsufficient p16(Ink4a)/p19(Arf) mice (gavage study).
National Toxicology Program
Natl Toxicol Program Genet Modif Model Rep; 2007 Nov; (13):1-81. PubMed ID: 18784757
[TBL] [Abstract][Full Text] [Related]
30. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
[TBL] [Abstract][Full Text] [Related]
31. NTP report on the toxicology and carcinogenesis study of benzene (CAS No. 71-43-2) in genetically modified haploinsufficient p16 Ink4a/p19 Arf mice (gavage study).
National Toxicology Program
Natl Toxicol Program Genet Modif Model Rep; 2007 Oct; (8):1-81. PubMed ID: 18784769
[TBL] [Abstract][Full Text] [Related]
32. p16
Novais EJ; Diekman BO; Shapiro IM; Risbud MV
Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
[TBL] [Abstract][Full Text] [Related]
33. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
34. Bmi1 suppresses protein synthesis and promotes proteostasis in hematopoietic stem cells.
Burgess RJ; Zhao Z; Nakada D; Morrison SJ
Genes Dev; 2022 Aug; 36(15-16):887-900. PubMed ID: 36167470
[TBL] [Abstract][Full Text] [Related]
35. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
[TBL] [Abstract][Full Text] [Related]
36. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
37. HMGA2, microRNAs, and stem cell aging.
Hammond SM; Sharpless NE
Cell; 2008 Dec; 135(6):1013-6. PubMed ID: 19070572
[TBL] [Abstract][Full Text] [Related]
38. N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice.
Morrison JP; Satoh H; Foley J; Horton JL; Dunnick JK; Kissling GE; Malarkey DE
Toxicol Pathol; 2007 Oct; 35(6):780-7. PubMed ID: 17943659
[TBL] [Abstract][Full Text] [Related]
39. Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.
Bardeesy N; Morgan J; Sinha M; Signoretti S; Srivastava S; Loda M; Merlino G; DePinho RA
Mol Cell Biol; 2002 Jan; 22(2):635-43. PubMed ID: 11756558
[TBL] [Abstract][Full Text] [Related]
40. Hmga2 regulates self-renewal of retinal progenitors.
Parameswaran S; Xia X; Hegde G; Ahmad I
Development; 2014 Nov; 141(21):4087-97. PubMed ID: 25336737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
